Log in to save to my catalogue

Integrated genetic and pharmacologic interrogation of rare cancers

Integrated genetic and pharmacologic interrogation of rare cancers

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a374f09a5d1640b381b40c1ebaec01db

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Identifying therapeutic targets in rare cancers remains challenging due to the paucity of established models to perform preclinical studies. As a proof-of-concept, we developed a patient-derived cancer cell line, CLF-PED-015-T, from a paediatric patient with a rare undifferentiated sarcoma. Here, we confirm that this cell line recapitulates the his...

Alternative Titles

Full title

Integrated genetic and pharmacologic interrogation of rare cancers

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a374f09a5d1640b381b40c1ebaec01db

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a374f09a5d1640b381b40c1ebaec01db

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/ncomms11987

How to access this item